Using high-resolution array-CGH, we identified unique duplications of a region on 6q27 in four multiplex families with at least three cases of chordoma, a cancer of presumed notochordal origin. The duplicated region contains only the T (brachyury) gene, which is important in notochord development and is expressed in most sporadic chordomas. Our findings highlight the value of screening for complex genomic rearrangements in searches for cancer-susceptibility genes.
(no. 44, 2 years of age at MRI evaluation) shared the 6q disease haplotype. Similarly, all chordoma-affected individuals and obligate gene carriers in family 3, and the two sisters affected with chordoma in family 4, shared a common haplotype in the 6q region. The minimal disease region defined by the three families was ~5 Mb. Family 2 did not show consistent evidence for linkage to this region. The minimal disease region contains several biologically relevant genes that may be important in chordoma and in cancers in general. Among them, the T gene, which encodes brachyury, is of particular interest. Brachyury is a tissue-specific transcription factor expressed in notochord cells 10 and is essential for proper development and maintenance of the notochord 11 . Brachyury is specifically expressed in chordomas but not in a wide variety of non-neoplastic tissues or in 42 other types of neoplasms, including chondrosarcomas 12 . Its expression in chordomas mimics its expression in the embryonic notochord. Given its obvious biological relevance, we selected the T gene as our top candidate for follow-up. We sequenced the coding region and adjacent splice sites of the nine exons and 5 kb upstream and downstream of the coding region of the T gene in DNA from ten affected individuals from families 1, 2, 4 and 6 (families 1-4 were included in the linkage analyses; families 6-8 were newly examined smaller chordoma-affected families; Table 1 and Supplementary Fig. 1 ). We did not find any sequence variants consistent with a disease-causing mutation. We also sequenced 20 other candidate genes that reside in the minimal disease locus region, including DACT2 and RPS6KA2, but did not find any disease-related mutations in them.
CNVs have recently been recognized as an important source of genetic variation that can contribute to disease susceptibility 1 . Therefore, we conducted a genome-wide search for CNVs using a whole-genome human array-comparative genomic hybridization (array-CGH) chip (Nimblegen 385K; average probe spacing, 7 kb). We analyzed blood-derived genomic DNA from 11 individuals with chordoma and two spouses selected from our seven chordoma-affected families (Supplementary Methods). We identified duplicated regions on 6q27 in seven affected individuals from four families: family 1 (nos. 18 and 21), family 3 (no. 3), family 4 (nos. 1 and 3) and family 8 (nos. 1 and 2) (Supplementary Table 2) . The sizes of the duplicated regions ranged from 52 kb in family 4 to 489 kb in family 3. The duplications were not detected in individuals with chordoma from families 2, 6 and 7, two unrelated spouse controls (from families 1 and 2) or 16 individuals from melanoma-prone families whose blood DNA was analyzed using the same assay (Supplementary Table 2) . The duplicated regions 
r i e F C o m m u n i C a T i o n s
in all four families contain only one known gene, T, and within the gene, there were no previously reported CNVs.
To validate the finding, we developed a quantitative PCR (qPCR) assay targeting the 3′ end of exon 6 in the T gene and screened for copy number changes in all 65 individuals (21 of them affected with chordoma) in the seven families for whom DNA was available. qPCR analyses confirmed the duplications in all affected subjects and obligate carriers in families 1, 3, 4 and 8 ( Table 1 and Supplementary  Fig. 2a) . 6q duplications were not observed in members of the other chordoma-affected families or in 100 unrelated healthy controls (200 meioses) (Supplementary Fig. 2b) . The aggregation of chordoma in the three families without the duplications, each with two chordomaaffected individuals, may result from alterations of other susceptibility genes, from another mutational mechanism targeting the T gene or from clustering of sporadic chordoma cases.
To confirm the T gene duplications and to better define the breakpoints of the amplicons, we analyzed genomic DNA from seven individuals with chordoma (nos. 1 and 5 in family 1, no. 3 in family 3, no. 3 in family 4, no. 1 in family 7 and no. 1 in family 8) and an unaffected individual in family 6 using a Nimblegen custom-made fine-tiling CGH array specifically targeting the 6q27 region (average probe spacing, 4 bp). Duplications of the T gene were clearly demonstrated in the individuals with chordoma from families 1, 3, 4 and 8 ( Fig. 1) . In contrast, no duplication was observed in the two 'controls' (an affected individual from family 7 who did not carry the duplication and an unaffected individual from family 6). Using the predicted breakpoints defined by the fine-tiling arrays, we were able to amplify junction fragments from three of the four families (families 1, 4 and 8).
The genomic rearrangement in family 3 is more complex than those in the other families, as evidenced by the CGH segmentation analysis (Fig. 1) . Families 1, 4 and 8 showed similar tandem duplications, and the duplication sizes were consistent with observed array-CGH changes (124,756 bp in family 1, 97,284 bp in family 4 and ~173 kb in family 8; Supplementary Fig. 3 ). Amplification of junction fragments was confirmed in all individuals of families 1, 4 and 8 who showed increased copy number of the T gene by qPCR ( Supplementary  Fig. 2a) . In contrast, we were not able to amplify from controls the junction fragments that were observed in families 1, 4 (200 unrelated controls) and 8 (100 unrelated controls).
Sequence analysis of the junction fragments identified the breakpoints (families 1 and 4) or breakpoint region (family 8). Bioinformatics analysis revealed that the breakpoints or breakpoint region were located at or near repetitive short and long interspersed repeat (SINE and LINE) elements, but they did not contain any low-copy repeats (LCRs) (Supplementary Fig. 3) . In family 1, a single base pair was shared between the telomeric and centromeric sequences at the breakpoint junction (Supplementary Fig. 3a) . In family 4, the telomeric and centromeric sequences were separated by a 5-bp insertion (Supplementary Fig. 3b) . In family 8, the junction fragment was located within a 306-bp region of high (90%) homology formed by the fusion of two AluY elements located at 6q27 (Supplementary Fig. 3c ). A precise breakpoint could not be located in this fused region as the junction fragment gradually transitioned from the telomeric AluY (chr. 6: 166,580,862-166,581,165) to the centromeric AluY (chr. 6: 166,406,935-166,407,246) sequence. The tandem duplication in family 8 most likely resulted from an AluYmediated nonallelic homologous recombination (NAHR). The junction fragments in family 1 and family 4 share features that seem to be consistent with nonhomologous end joining (NHEJ), although the underlying mechanism could be more complex, as suggested in recent publications 13 .
In summary, we have identified T as a major susceptibility gene for familial chordoma using combined genetic linkage and highresolution array-CGH analyses. This approach enabled us to identify a susceptibility gene in a linkage region that did not reveal diseaseassociated mutations by sequencing. Our findings suggest that screening for complex genomic rearrangements that co-segregate with disease in families may provide a powerful alternative to traditional gene-mapping approaches.
